Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

PJ SCIENCE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   5.6% 6.8% 6.5% 5.4% 4.1% 3.4% 16.2% 16.0%   Credit score (0-100)   42 36 36 40 49 53 11 12   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   189 275 546 431 154 111 0.0 0.0   EBITDA   189 275 546 431 154 111 0.0 0.0   EBIT   182 275 546 431 154 111 0.0 0.0   Pre-tax profit (PTP)   181.5 274.6 545.7 430.2 151.4 115.2 0.0 0.0   Net earnings   140.7 216.4 425.6 335.2 118.1 89.6 0.0 0.0   Pre-tax profit without non-rec. items   181 275 546 430 151 115 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   307 418 594 503 286 376 -89.1 -89.1   Interest-bearing liabilities   375 0.0 0.0 169 267 300 89.1 89.1   Balance sheet total (assets)   739 461 863 863 724 1,451 0.0 0.0   Net Debt   57.4 -111 -42.6 95.1 128 -261 89.1 89.1     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   189 275 546 431 154 111 0.0 0.0   Gross profit growth   -61.5% 45.6% 98.7% -21.1% -64.2% -28.1% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   739 461 863 863 724 1,451 0 0   Balance sheet change%   97.5% -37.6% 87.4% -0.0% -16.1% 100.5% -100.0% 0.0%   Added value   188.6 274.6 545.7 430.7 154.2 110.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -14 0 0 0 263 269 -532 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   96.4% 100.0% 100.0% 100.0% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   32.7% 45.8% 82.4% 49.9% 19.4% 10.6% 0.0% 0.0%   ROI %   37.5% 49.9% 107.8% 68.0% 25.2% 18.4% 0.0% 0.0%   ROE %   47.4% 59.7% 84.1% 61.1% 29.9% 27.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   41.6% 90.8% 68.8% 58.3% 39.5% 25.9% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   30.4% -40.3% -7.8% 22.1% 82.7% -235.8% 0.0% 0.0%   Gearing %   122.2% 0.0% 0.0% 33.6% 93.2% 79.8% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.1% 0.0% 0.0% 0.6% 1.3% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.7 10.9 3.2 2.4 1.1 0.9 0.0 0.0   Current Ratio   1.7 10.9 3.2 2.4 1.1 0.9 0.0 0.0   Cash and cash equivalent   317.6 110.7 42.6 73.8 139.2 561.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   307.0 418.4 594.0 503.2 23.7 -133.2 -44.6 -44.6   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0